Terug
Dagbereik
€ 199,65
€ 203,93
52-Weeksbereik
€ 118,73
€ 218,00
Volume
274.282
50D / 200D Gem.
€ 196,18
/
€ 174,81
Vorige Slotkoers
€ 202,43
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 34,3 | 0,3 |
| P/B | 5,3 | 2,9 |
| ROE % | 16,9 | 3,7 |
| Net Margin % | 6,8 | 3,8 |
| Rev Growth 5Y % | 17,8 | 10,0 |
| D/E | 1,9 | 0,2 |
Koersdoel Analisten
Hold
€ 222,33
+9.6%
Low: € 215,00
High: € 230,00
Forward K/W
26,9
Forward WPA
€ 7,52
WPA Groei (sch.)
+0,0%
Omzet Sch.
5,8 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2028 |
€ 8,98
€ 8,89 – € 9,07
|
6,9 B | 2 |
| FY2027 |
€ 8,24
€ 8,00 – € 8,47
|
6,3 B | 3 |
| FY2026 |
€ 7,52
€ 7,51 – € 7,57
|
5,8 B | 3 |
Belangrijkste Punten
Revenue grew 17,79% annually over 5 years — strong growth
Earnings grew 15,44% over the past year
ROE of 16,91% — decent returns on equity
Generating 370,71M in free cash flow
P/E of 34,28 — premium valuation
Cash machine — converts 107,77% of earnings into free cash flow
Groei
Revenue Growth (5Y)
17,79%
Revenue (1Y)18,72%
Earnings (1Y)15,44%
FCF Growth (3Y)17,07%
Kwaliteit
Return on Equity
16,91%
ROIC5,09%
Net Margin6,80%
Op. Margin8,58%
Veiligheid
Debt / Equity
1,86
Current Ratio1,42
Interest Coverage54,31
Waardering
P/E Ratio
34,28
P/B Ratio5,28
EV/EBITDA35,60
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 18,72% | Revenue Growth (3Y) | 16,46% |
| Earnings Growth (1Y) | 15,44% | Earnings Growth (3Y) | 28,17% |
| Revenue Growth (5Y) | 17,79% | Earnings Growth (5Y) | 15,30% |
| Profitability | |||
| Revenue (TTM) | 5,06B | Net Income (TTM) | 343,97M |
| ROE | 16,91% | ROA | 6,30% |
| Gross Margin | 13,74% | Operating Margin | 8,58% |
| Net Margin | 6,80% | Free Cash Flow (TTM) | 370,71M |
| ROIC | 5,09% | FCF Growth (3Y) | 17,07% |
| Safety | |||
| Debt / Equity | 1,86 | Current Ratio | 1,42 |
| Interest Coverage | 54,31 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 34,28 | P/B Ratio | 5,28 |
| P/S Ratio | 2,33 | PEG Ratio | 2,06 |
| EV/EBITDA | 35,60 | Dividend Yield | 0,00% |
| Market Cap | 11,79B | Enterprise Value | 15,44B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 5,06B | 4,26B | 3,73B | 3,03B | 2,63B |
| Net Income | 343,97M | 297,97M | 209,40M | 224,68M | 194,65M |
| EPS (Diluted) | 5,84 | 5,12 | 3,65 | 3,95 | 3,42 |
| Gross Profit | 695,13M | 667,59M | 590,76M | 517,99M | 468,21M |
| Operating Income | 433,80M | 358,30M | 255,37M | 296,83M | 260,47M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5,46B | 4,67B | 4,18B | 3,45B | 2,85B |
| Total Liabilities | 3,23B | 2,83B | 2,68B | 2,20B | 1,83B |
| Shareholders' Equity | 2,23B | 1,84B | 1,49B | 1,25B | 1,02B |
| Total Debt | 4,15B | 1,97B | 1,87B | 1,57B | 1,27B |
| Cash & Equivalents | 503,88M | 464,60M | 509,63M | 316,27M | 262,20M |
| Current Assets | 1,27B | 1,16B | 1,05B | 781,13M | 639,71M |
| Current Liabilities | 894,35M | 743,43M | 734,75M | 582,07M | 523,07M |